nasdaq:mack
|
26431
|
Mar 23rd, 2024 12:00AM
|
Merrimack
|
8.5K
|
68.00
|
Open
|
|
Mar 22nd, 2024 11:53PM
|
Mar 23rd, 2024 07:02PM
|
Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes.
For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma.
|
Open
|
Oncology and Network Biology
|
Open
|
One Kendall Square
|
Cambridge
|
Massachusetts
|
US
|
02139
|
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mack
|
26431
|
Mar 22nd, 2024 12:00AM
|
Merrimack
|
8.5K
|
68.00
|
Open
|
|
Mar 21st, 2024 11:43PM
|
Mar 22nd, 2024 06:50PM
|
Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes.
For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma.
|
Open
|
Oncology and Network Biology
|
Open
|
One Kendall Square
|
Cambridge
|
Massachusetts
|
US
|
02139
|
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mack
|
26431
|
Mar 21st, 2024 12:00AM
|
Merrimack
|
8.5K
|
68.00
|
Open
|
|
Mar 20th, 2024 11:56PM
|
Mar 21st, 2024 05:34PM
|
Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes.
For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma.
|
Open
|
Oncology and Network Biology
|
Open
|
One Kendall Square
|
Cambridge
|
Massachusetts
|
US
|
02139
|
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mack
|
26431
|
Mar 20th, 2024 12:00AM
|
Merrimack
|
8.5K
|
68.00
|
Open
|
|
Mar 20th, 2024 12:37AM
|
Mar 20th, 2024 07:35PM
|
Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes.
For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma.
|
Open
|
Oncology and Network Biology
|
Open
|
One Kendall Square
|
Cambridge
|
Massachusetts
|
US
|
02139
|
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mack
|
26431
|
Mar 19th, 2024 12:00AM
|
Merrimack
|
8.5K
|
68.00
|
Open
|
|
Mar 18th, 2024 11:31PM
|
Mar 19th, 2024 06:07PM
|
Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes.
For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma.
|
Open
|
Oncology and Network Biology
|
Open
|
One Kendall Square
|
Cambridge
|
Massachusetts
|
US
|
02139
|
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mack
|
26431
|
Mar 18th, 2024 12:00AM
|
Merrimack
|
8.5K
|
68.00
|
Open
|
|
Mar 17th, 2024 11:53PM
|
Mar 18th, 2024 07:19PM
|
Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes.
For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma.
|
Open
|
Oncology and Network Biology
|
Open
|
One Kendall Square
|
Cambridge
|
Massachusetts
|
US
|
02139
|
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mack
|
26431
|
Mar 16th, 2024 12:00AM
|
Merrimack
|
8.5K
|
68.00
|
Open
|
|
Mar 15th, 2024 11:23PM
|
Mar 16th, 2024 07:07PM
|
Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes.
For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma.
|
Open
|
Oncology and Network Biology
|
Open
|
One Kendall Square
|
Cambridge
|
Massachusetts
|
US
|
02139
|
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mack
|
26431
|
Mar 15th, 2024 12:00AM
|
Merrimack
|
8.5K
|
68.00
|
Open
|
|
Mar 15th, 2024 12:55AM
|
Mar 15th, 2024 08:56AM
|
Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes.
For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma.
|
Open
|
Oncology and Network Biology
|
Open
|
One Kendall Square
|
Cambridge
|
Massachusetts
|
US
|
02139
|
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mack
|
26431
|
Mar 14th, 2024 12:00AM
|
Merrimack
|
8.5K
|
68.00
|
Open
|
|
Mar 13th, 2024 11:20PM
|
Mar 14th, 2024 12:17PM
|
Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes.
For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma.
|
Open
|
Oncology and Network Biology
|
Open
|
One Kendall Square
|
Cambridge
|
Massachusetts
|
US
|
02139
|
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mack
|
26431
|
Mar 13th, 2024 12:00AM
|
Merrimack
|
8.5K
|
68.00
|
Open
|
|
Mar 12th, 2024 11:16PM
|
Mar 13th, 2024 10:48AM
|
Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes.
For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma.
|
Open
|
Oncology and Network Biology
|
Open
|
One Kendall Square
|
Cambridge
|
Massachusetts
|
US
|
02139
|
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|